These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38223595)

  • 1. Aflatoxin exposure in a population of HIV patients at risk of hepatocellular carcinoma North-Central, Nigeria.
    Davwar P; David P; Imoh L; Duguru M; Zawaya K; Tsok Y; Sagay A; Okeke E
    Afr Health Sci; 2023 Jun; 23(2):81-87. PubMed ID: 38223595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aflatoxin levels and prevalence of TP53 aflatoxin-mutations in hepatocellular carcinomas in Mexico.
    Lino-Silva LS; Lajous M; Brochier M; Santiago-Ruiz L; Melchor-Ruan J; Xie Y; Wang M; Wu D; Higson H; Jones K; Romero-Martínez M; Villalpando S; Mohar A; Smith JW; Alvarez CS; McGlynn KA; Dean M; Groopman J
    Salud Publica Mex; 2022 Feb; 64(1):35-40. PubMed ID: 35438902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Features of Aflatoxin-Associated Hepatocellular Carcinoma.
    Zhang W; He H; Zang M; Wu Q; Zhao H; Lu LL; Ma P; Zheng H; Wang N; Zhang Y; He S; Chen X; Wu Z; Wang X; Cai J; Liu Z; Sun Z; Zeng YX; Qu C; Jiao Y
    Gastroenterology; 2017 Jul; 153(1):249-262.e2. PubMed ID: 28363643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aflatoxins as a risk factor for hepatocellular carcinoma in Egypt, Mansoura Gastroenterology Center study.
    Abdel-Wahab M; Mostafa M; Sabry M; el-Farrash M; Yousef T
    Hepatogastroenterology; 2008; 55(86-87):1754-9. PubMed ID: 19102385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The association between aflatoxin exposure and primary hepatocellular carcinoma risks: a case-control study in Chongqing].
    Zheng CF; Zeng H; Wang J; Lin H; Feng XB; Chen JA; Qiu ZQ; Luo JH; Xu AW; Wang LQ; Tan Y; Chen S; Jiang P; Shu WQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):539-545. PubMed ID: 28592100
    [No Abstract]   [Full Text] [Related]  

  • 6. Interaction of DNA repair gene polymorphisms and aflatoxin B1 in the risk of hepatocellular carcinoma.
    Yao JG; Huang XY; Long XD
    Int J Clin Exp Pathol; 2014; 7(9):6231-44. PubMed ID: 25337275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms in DNA repair genes XRCC4 and XRCC5 and aflatoxin B1-related hepatocellular carcinoma.
    Long XD; Zhao D; Wang C; Huang XY; Yao JG; Ma Y; Wei ZH; Liu M; Zeng LX; Mo XQ; Zhang JJ; Xue F; Zhai B; Xia Q
    Epidemiology; 2013 Sep; 24(5):671-81. PubMed ID: 23788213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.
    Shirabe K; Toshima T; Taketomi A; Taguchi K; Yoshizumi T; Uchiyama H; Harimoto N; Kajiyama K; Egashira A; Maehara Y
    Liver Int; 2011 Oct; 31(9):1366-72. PubMed ID: 21745313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinogenic effects of aflatoxin B1 among wheat handlers.
    Saad-Hussein A; Taha MM; Beshir S; Shahy EM; Shaheen W; Elhamshary M
    Int J Occup Environ Health; 2014; 20(3):215-9. PubMed ID: 25000109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Present and future directions of translational research on aflatoxin and hepatocellular carcinoma. A review.
    Wogan GN; Kensler TW; Groopman JD
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2012; 29(2):249-57. PubMed ID: 21623489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aflatoxins as a cause of hepatocellular carcinoma.
    Kew MC
    J Gastrointestin Liver Dis; 2013 Sep; 22(3):305-10. PubMed ID: 24078988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of aflatoxin, mutant P53 gene and sIL-2 receptor in liver cirrhosis and hepatocellular carcinoma.
    El-Shanawani FM; Abdel-Hadi AA; Abu Zikri NB; Ismail A; El-Ansary M; El-Raai A
    J Egypt Soc Parasitol; 2006 Apr; 36(1):221-39. PubMed ID: 16605112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aflatoxin B1: metabolism, toxicology, and its involvement in oxidative stress and cancer development.
    Cao W; Yu P; Yang K; Cao D
    Toxicol Mech Methods; 2022 Jul; 32(6):395-419. PubMed ID: 34930097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi Autonomous Region, People's Republic of China.
    Groopman JD; Zhu JQ; Donahue PR; Pikul A; Zhang LS; Chen JS; Wogan GN
    Cancer Res; 1992 Jan; 52(1):45-52. PubMed ID: 1727385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet.
    Hsia CC; Kleiner DE; Axiotis CA; Di Bisceglie A; Nomura AM; Stemmermann GN; Tabor E
    J Natl Cancer Inst; 1992 Nov; 84(21):1638-41. PubMed ID: 1279184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic alterations caused by aflatoxin b1: a public health risk in the induction of hepatocellular carcinoma.
    Ferreira RG; Cardoso MV; de Souza Furtado KM; Espíndola KMM; Amorim RP; Monteiro MC
    Transl Res; 2019 Feb; 204():51-71. PubMed ID: 30304666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aflatoxin and liver cancer.
    Jackson PE; Groopman JD
    Baillieres Best Pract Res Clin Gastroenterol; 1999 Dec; 13(4):545-55. PubMed ID: 10654919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.
    Szymañska K; Chen JG; Cui Y; Gong YY; Turner PC; Villar S; Wild CP; Parkin DM; Hainaut P
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1638-43. PubMed ID: 19366907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Aflatoxin-Associated
    Jiao J; Niu W; Wang Y; Baggerly K; Ye Y; Wu X; Davenport D; Almeda JL; Betancourt-Garcia MM; Forse RA; Stevenson HL; Watt GP; McCormick JB; Fisher-Hoch SP; Beretta L
    Cancer Prev Res (Phila); 2018 Feb; 11(2):103-112. PubMed ID: 29089331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aflatoxin and p53 abnormality in duck hepatocellular carcinoma.
    Imazeki F; Yokosuka O; Ohto M; Omata M
    J Gastroenterol Hepatol; 1995; 10(6):646-9. PubMed ID: 8580407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.